Jim Simons
CRCA icon

Jim Simons’s ProShares Ultra CRCL CRCA Stock Holding History

Jim Simons’s Portfolio CRCA Stock Details CRCA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$449K Buy
+25,800
New +$452K ﹤0.01% 2656

Other funds holding CRCA

Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Hollencrest Capital Management
Hollencrest Capital Management Newport Beach, California $1.56B AUM 20.98% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $184B AUM 51.71% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $73.3B AUM 63.67% 1-Year Est. Return

Jim Simons's CRCA Position: Q3 2026 in Review

Jim Simons opened a new position in ProShares Ultra CRCL (CRCA) in Q3 2026: 25,800 shares worth $449K. The stake represents ﹤0.01% of the portfolio and ranks #2656 among its holdings.

6 funds tracked by Wall St. Rank hold CRCA as of Q3 2026.

  • Jim Simons held 25,800 shares of ProShares Ultra CRCL worth $449K as of Q3 2026.
  • ProShares Ultra CRCL was a new Jim Simons position in Q3 2026.
  • ProShares Ultra CRCL made up ﹤0.01% of Jim Simons's portfolio in Q3 2026, its #2656 holding.
  • 6 funds tracked by Wall St. Rank held ProShares Ultra CRCL as of Q3 2026.

Based on Renaissance Technologies's 13F filing for Q3 2026, filed 12 Nov 2026.